These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Topical anti-inflammatory treatments for eczema: network meta-analysis. Lax SJ; Van Vogt E; Candy B; Steele L; Reynolds C; Stuart B; Parker R; Axon E; Roberts A; Doyle M; Chu DK; Futamura M; Santer M; Williams HC; Cro S; Drucker AM; Boyle RJ Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015064. PubMed ID: 39105474 [TBL] [Abstract][Full Text] [Related]
4. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134 [TBL] [Abstract][Full Text] [Related]
5. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis. Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119 [TBL] [Abstract][Full Text] [Related]
6. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. Devasenapathy N; Chu A; Wong M; Srivastava A; Ceccacci R; Lin C; MacDonald M; Wen A; Steen J; Levine M; Pyne L; Schneider L; Chu DK; Lancet Child Adolesc Health; 2023 Jan; 7(1):13-25. PubMed ID: 36370744 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Breuer K; Werfel T; Kapp A Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y; Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983 [TBL] [Abstract][Full Text] [Related]
10. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. Chu DK; Chu AWL; Rayner DG; Guyatt GH; Yepes-Nuñez JJ; Gomez-Escobar L; Pérez-Herrera LC; Díaz Martinez JP; Brignardello-Petersen R; Sadeghirad B; Wong MM; Ceccacci R; Zhao IX; Basmaji J; MacDonald M; Chu X; Islam N; Gao Y; Izcovich A; Asiniwasis RN; Boguniewicz M; De Benedetto A; Capozza K; Chen L; Ellison K; Frazier WT; Greenhawt M; Huynh J; LeBovidge J; Lio PA; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Smith Begolka W; Wang J; Wheeler KE; Gardner DD; Schneider L J Allergy Clin Immunol; 2023 Dec; 152(6):1493-1519. PubMed ID: 37678572 [TBL] [Abstract][Full Text] [Related]
11. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis. Fröschl B; Arts D; Leopold C GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943 [TBL] [Abstract][Full Text] [Related]
12. Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis. Sun SL; Liu JJ; Zhong B; Wang JK; Jin X; Xu H; Yin FY; Liu TN; Chen QM; Zeng X Br J Dermatol; 2019 Dec; 181(6):1166-1176. PubMed ID: 30903622 [TBL] [Abstract][Full Text] [Related]
13. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. Wellington K; Jarvis B Drugs; 2002; 62(5):817-40. PubMed ID: 11929333 [TBL] [Abstract][Full Text] [Related]
14. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials. Chen SL; Yan J; Wang FS J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490 [TBL] [Abstract][Full Text] [Related]
15. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis. Hebert AA Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454 [TBL] [Abstract][Full Text] [Related]
16. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708 [TBL] [Abstract][Full Text] [Related]
17. Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis. Chia BK; Tey HL Dermatitis; 2015; 26(3):122-32. PubMed ID: 25984688 [TBL] [Abstract][Full Text] [Related]
18. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis]. Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186 [TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas. Luger T; Chu CY; Elgendy A; Ibrahim SBBK; Murashkin N; Ranjan S; Zhao Z Eur J Dermatol; 2023 Oct; 33(5):474-486. PubMed ID: 38297923 [TBL] [Abstract][Full Text] [Related]
20. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits. Ohtsuki M; Morimoto H; Nakagawa H J Dermatol; 2018 Aug; 45(8):936-942. PubMed ID: 29927498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]